Publications by authors named "Esmen Baltali"

Claim this Profile
E
Expression of PTEN, cyclin D1, P27/KIP1 in invasive ductal carcinomas of the breast and correlation with clinicopathological parameters.
Hüseyin Engin, Esmen Baltali, Nilüfer Güler, Gülnur Güler, Gülten Tekuzman

Bull Cancer· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embryonal rhabdomyosarcoma of the larynx.
Oguz Dikbas, Kadri Altundag, Huseyin Abali, Alev Turker, Huseyin Engin, Esmen Baltali

Otolaryngol Head Neck Surg· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer.
Mustafa Erman, Esmen Baltali, Aziz Karaoglu, Huseyin Abali, Huseyin Engin

Cancer Invest· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy with cyclophosphamide, mitoxantrone, and 5-fluorouracil in locally advanced breast cancer.
Kutlu Erol, Esmen Baltali, Kadri Altundag, Nilufer Guler, Yavuz Ozisik

Onkologie· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women: a case-control study.
Betul Oran, Ismail Celik, Mustafa Erman, Esmen Baltali, Nurullah Zengin

Med Oncol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel in pretreated metastatic breast cancer: retrospective analysis of 52 patients.
Esmen Baltali, Kadri Altundag, Yavuz Ozisik, Nilufer Guler, Gulten Tekuzman

Tohoku J Exp Med· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis to the breast from nonmammarian solid neoplasms: a report of five cases.
Berna Oksüzoğlu, Hüseyin Abali, Nilüfer Güler, Eşmen Baltali, Yavuz Ozişik

Med Oncol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer and splenic non-Hodgkin's lymphoma, a rare occurrence.
Hüseyin Engin, Eşmen Baltali, Başak Oyan, Hüsnü Göksel, Banu Demirel

Breast J· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: a preliminary report.
Eşmen Baltali, M Kadri Altundağ, Demir Ali Onat, Osman Abbasoğlu, Yavuz Ozişik

Tumori· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.
Mehmet Akif Oztürk, Ibrahim Barişta, M Kadri Altundağ, Alev Türker, Suayib Yalçin, Eşmen Baltali

Chemotherapy· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer.
Eşmen Baltali, M Kadri Altundağ, Nilüfer Güler, Yavuz Ozişik, Dinçer Firat

Tumori· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis